Aggravation of Inflammatory Bowel Disease by Cyclooxygenase-2 Inhibitors in Rats

Publisher： Karger

E-ISSN： 1423-0313|72|2|77-84

ISSN： 0031-7012

Source： Pharmacology, Vol.72, Iss.2, 2004-09, pp. : 77-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Cyclo-Oxygenase Inhibitors Is Not Associated with Clinical Relapse in Inflammatory Bowel Disease: A Case-Control Study

By Hensley Abigail   Beales Ian L. P.  

Pharmaceuticals, Vol. 8, Iss. 3, 2015-09 ,pp. : 512-524

MDPI

Access to resources Recommend Favorite

Gastric Damage Induced by Subchronic Administration of Preferential Cyclooxygenase-1 and Cyclooxygenase-2 Inhibitors in Rats

By  

Pharmacology, Vol. 66, Iss. 2, 2002-09 ,pp. : 68-75

Karger

Access to resources Recommend Favorite

Flavonoids in Inflammatory Bowel Disease: A Review

By Vezza Teresa   Rodríguez-Nogales Alba   Algieri Francesca   Utrilla Maria Pilar   Rodriguez-Cabezas Maria Elena   Galvez Julio  

Nutrients, Vol. 8, Iss. 4, 2016-04 ,pp. : 211-211

MDPI

Access to resources Recommend Favorite

Anti-Inflammatory Effect and Low Ulcerogenic Activity of Etodolac, a Cyclooxygenase-2 Selective Non-Steroidal Anti-Inflammatory Drug, on Adjuvant-Induced Arthritis in Rats

By  

Pharmacology, Vol. 68, Iss. 2, 2003-05 ,pp. : 96-104

Karger

Access to resources Recommend Favorite

Combined Treatment with Hyaluronic Acid and Mesalamine Protects Rats from Inflammatory Bowel Disease Induced by Intracolonic Administration of Trinitrobenzenesulfonic Acid

By Chiu Chih-Tung   Kuo Sheng-Nan   Hung Shao-Wen   Yang Cheng-Yao  

Molecules, Vol. 22, Iss. 6, 2017-05 ,pp. : 904-904

MDPI

Access to resources Recommend Favorite